Project Grant D71TW009139

This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $824,284 to the University of Massachusetts Medical School for a 5-year longitudinal study. The study aims to: (1) measure the association between residential segregation and age acceleration in black adults over the life course, and (2) identify neighborhood-level mechanisms linking residential segregation to physiological...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $562,641 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Baylor College of Medicine to support the "Cardiovascular Research and Drug Development (CRDD) Training Program." This 5-year program aims to train a diverse group of predoctoral (Ph.D. and MD/Ph.D.) students in cardiovascular research and therapeutic development. Key elements include formal coursework, responsible conduct of...

This $165,364 federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research to identify novel contextual and genomic blood pressure measures to enhance cardiovascular disease prediction and management among young adults aged 18 to 39 years. The key objectives are to: Identify novel ambulatory blood pressure patterns capturing dynamic responses to everyday factors using machine learning approaches. Derive a...

This federal Project Grant award, totaling $132,410 and awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports research and mentoring initiatives focused on cardiovascular disease epidemiology, health equity, and health disparities. The award provides protected time for Dr. Cheryl Anderson, a mid-career clinical investigator, to recruit and mentor a diverse group of trainees in these research areas. The...

This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will provide $123,104 to Emory University to conduct research focused on understanding the relationship between the HIV reservoir, metabolic profiles, and cardiovascular disease risk in persons living with HIV, with a specific focus on sex differences. The research aims to: 1) assess the relationships between the metabolome, lipidome, HIV reservoir,...

This $162,000 Project Grant award, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), will support the development and implementation of a comprehensive, equity-driven training program at the University of South Carolina. The program aims to build capacity and expertise among 12 junior scholars in integrating community engagement, health communication, and implementation science research to advance the understanding of social determinants of health and...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $733,805 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to The Regents of the University of California, San Francisco (UCSF) to conduct a 6-month randomized controlled trial. The objective is to test the efficacy of a virtual coaching and social support intervention to improve physical activity (PA), psychosocial, social cognitive, and clinical outcomes for older adults (age 60+) exiting cardiac rehabilitation and...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $421,066 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Vanderbilt University Medical Center (VUMC) to establish the Vanderbilt Interdisciplinary Hospital-Based Systems of Care Research and Training Program (VISTA). This two-year program will train three postdoctoral investigators per year to conduct patient-oriented and health systems research focused on acute heart, lung, or blood disorders in the hospital...

This Project Grant award from the National Heart Lung and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $190,491 to Beth Israel Deaconess Medical Center, Inc. (Bidmc) to conduct research on plasma protein markers associated with blood pressure response during exercise. The key objectives are to: Identify circulating proteins related to exercise blood pressure that may be predictive of future hypertension and cardiovascular disease risk, using...

This $874,792 Project Grant award is provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) federal grant program. The award to Vanderbilt University Medical Center (VUMC) aims to advance research on understanding and controlling the residual risk of atherosclerotic cardiovascular disease (ASCVD) among patients on treatment to lower low-density lipoprotein cholesterol (LDL-C) and blood pressure. The key research objectives are...